🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,39 USD

Máx. histórico

61,25

1786 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-52,02%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-0,20%

Cierre anterior

29,88

Rango de hoy

28,54 – 29,43

Volumen hoy

48.232.765

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,99 (puede no estar actualizado)
Dividend yield
5,76% (puede no estar actualizado)
Precio objetivo analistas
29,72 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 1 día
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,2900 USD · Yield: 4,39%
Fecha de pago Importe por participación
03/08/2011 0,1898 USD
11/05/2011 0,1898 USD
02/02/2011 0,1898 USD
04/11/2010 0,1708 USD
04/08/2010 0,1708 USD
05/05/2010 0,1708 USD
03/02/2010 0,1708 USD
04/11/2009 0,1518 USD
05/08/2009 0,1518 USD
06/05/2009 0,1518 USD
04/02/2009 0,3036 USD
05/11/2008 0,3036 USD
06/08/2008 0,3036 USD
07/05/2008 0,3036 USD
06/02/2008 0,3036 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
31/07/2024 31,20 31,26 30,47 30,54 -2,71% 2,53% 40.978.700
30/07/2024 31,01 31,54 29,78 31,39 +2,18% 5,68% 89.857.500
29/07/2024 30,69 30,93 30,44 30,72 -0,16% 1,60% 41.713.700
26/07/2024 30,15 30,88 30,01 30,77 +1,95% 2,89% 35.657.100
25/07/2024 29,97 30,93 29,97 30,18 +0,67% 3,20% 42.296.200
24/07/2024 29,51 29,99 29,31 29,98 +1,63% 2,30% 29.579.400
23/07/2024 29,62 29,64 29,33 29,50 -0,34% 1,05% 25.528.300
22/07/2024 30,11 30,23 29,38 29,60 -1,23% 2,82% 46.483.200
19/07/2024 29,94 30,00 29,55 29,97 +0,88% 1,50% 30.021.200
18/07/2024 29,91 30,69 29,63 29,71 -1,07% 3,54% 47.279.700
17/07/2024 29,42 30,30 29,31 30,03 +1,80% 3,37% 45.395.000
16/07/2024 29,20 29,56 29,12 29,50 +1,37% 1,51% 26.912.100
15/07/2024 29,03 29,27 28,83 29,10 +0,62% 1,52% 30.534.400
12/07/2024 28,90 29,14 28,79 28,92 +0,91% 1,21% 28.397.000
11/07/2024 28,78 29,23 28,42 28,66 +1,09% 2,81% 47.322.600
10/07/2024 27,83 28,41 27,80 28,35 +2,27% 2,19% 29.873.600
09/07/2024 27,88 27,94 27,30 27,72 -0,75% 2,30% 36.867.800
08/07/2024 28,05 28,12 27,79 27,93 -0,43% 1,18% 25.694.400
05/07/2024 27,76 28,09 27,67 28,05 +1,26% 1,51% 17.268.700
03/07/2024 27,92 28,05 27,62 27,70 -0,47% 1,54% 15.180.100
02/07/2024 28,22 28,28 27,69 27,83 -1,38% 2,09% 21.989.800
01/07/2024 27,95 28,63 27,94 28,22 +0,86% 2,47% 26.209.000
28/06/2024 27,78 28,12 27,64 27,98 +0,65% 1,73% 33.189.200
27/06/2024 27,37 27,83 27,07 27,80 +1,39% 2,78% 28.399.600
26/06/2024 27,91 27,93 27,07 27,42 -2,04% 3,08% 30.745.800
25/06/2024 28,40 28,45 27,93 27,99 -1,30% 1,83% 24.721.600
24/06/2024 27,95 28,41 27,73 28,36 +2,24% 2,43% 35.414.100
21/06/2024 27,77 27,89 27,56 27,74 +0,00% 1,19% 52.487.000
20/06/2024 27,20 27,96 27,15 27,74 +1,20% 2,98% 29.693.400
18/06/2024 26,98 27,46 26,95 27,41 +1,59% 1,89% 29.817.800